← Every company
Neurocrine Biosciences Inc SEC Filings
What Neurocrine Biosciences Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
NBIX overview →Filings on file
129
since Nov 2, 2016
Warning signs
0
none filed
Last results
Jul 30, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Sep 28, 2026 | Executive or director change 8-K | Read ↗ |
| May 28, 2026 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Nov 24, 2025 | Executive or director change 8-K | Read ↗ |
| May 30, 2025 | Executive or director change 8-K | Read ↗ |
| May 22, 2025 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Apr 4, 2025 | Executive or director change 8-K | Read ↗ |
| Oct 11, 2024 | Executive or director change 8-K | Read ↗ |
| May 28, 2024 | Executive or director change 8-K | Read ↗ |
| May 23, 2024 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jul 13, 2023 | Executive or director change 8-K | Read ↗ |
| Jul 12, 2023 | Executive or director change 8-K | Read ↗ |
| May 19, 2023 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 23, 2022 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Apr 16, 2021 | Executive or director change 8-K | Read ↗ |
| May 21, 2020 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Apr 9, 2020 | Executive or director change 8-K | Read ↗ |
| Feb 4, 2020 | Executive or director changeResults announced 8-K | Read ↗ |
| Sep 11, 2019 | Executive or director change 8-K | Read ↗ |
| May 23, 2019 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Sep 24, 2018 | Executive or director change 8-K | Read ↗ |
| May 30, 2018 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Feb 9, 2018 | Executive or director change 8-K | Read ↗ |
| Jan 8, 2018 | Executive or director changeResults announced 8-K | Read ↗ |
| Dec 5, 2017 | Executive or director change 8-K | Read ↗ |
| Oct 19, 2017 | Executive or director change 8-K | Read ↗ |
| Oct 10, 2017 | Executive or director changeMaterial agreement 8-K | Read ↗ |
| May 24, 2017 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Feb 10, 2017 | Executive or director changeMaterial agreement 8-K | Read ↗ |
| Jan 6, 2017 | Executive or director change 8-K | Read ↗ |
| Dec 23, 2016 | Executive or director change 8-K | Read ↗ |
Source: Neurocrine Biosciences Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on NBIX
Company overviewEverything on NBIX in one place, with the price.Insider tradingWhat NBIX's own officers and directors buy and sell.Planned salesSales NBIX insiders have filed notice of.Executive payWhat NBIX awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in NBIX.Funds holding itWhich funds and ETFs hold NBIX, and how big a bet.LobbyingWhat NBIX spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on NBIX's account, and who they worked for.PatentsWhat NBIX is filing at the patent office.